ALONSO ABAD, Ariel

Email Alert RSS Feed

Profile

Full Name
ALONSO ABAD, Ariel
Email
ariel.alonsoabad@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Date Issued:  [2010 TO 2019]
Internal UHasselt:  VAN DER ELST, Wim

Results 1-14 of 14 (Search time: 0.005 seconds).

Issue DateTitleContributor(s)TypeCat.
12019A reflection on the possibility of finding a good surrogateALONSO ABAD, Ariel; MEYVISCH, Paul; VAN DER ELST, Wim; MOLENBERGHS, Geert; VERBEKE, GeertJournal ContributionA1
22019A reflection on the causal interpretation of individual-level surrogacyALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, Geert; Florez, Alvaro J.Journal ContributionA1
32018PREDICTIVE BIOMARKERS OF TREATMENT SUCCESS IN ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS USING MULTIVARIATE CAUSAL INFERENCE.Lorenzo-Luaces, P.; Saavedra, D.; VAN DER ELST, Wim; ALONSO ABAD, Ariel; Viada Gonzalez, C.; SANCHEZ, LizetJournal ContributionM
42018A maximum entropy approach for the evaluation of surrogate endpoints based on causal inferenceALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, GeertJournal ContributionA1
52018Evaluation of six months sputum culture conversion as a surrogate endpoint in a multidrug resistant-tuberculosis trialMEYVISCH, Paul; Kambili, Chrispin; Andries, Koen; Lounis, Nacer; Theeuwes, Myriam; Dannemann, Brian; Vandebosch, An; VAN DER ELST, Wim; MOLENBERGHS, Geert; ALONSO ABAD, ArielJournal ContributionA1
62018Statistical evaluation of surrogate endpoints in cancer clinical trialsBUYSE, Marc; MOLENBERGHS, Geert; PAOLETTI, Xavier; Oba, K.; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, TomaszBook SectionB2
72017The R Package SurrogateVAN DER ELST, Wim; ALONSO ABAD, Ariel; MOLENBERGHS, GeertBook SectionB2
82017Applied Surrogate Endpoint Evaluation Methods with SAS and RALONSO ABAD, Ariel; BIGIRUMURAME, Theophile; BURZYKOWSKI, Tomasz; BUYSE, Marc; MOLENBERGHS, Geert; MUCHENE, Leacky; PERUALILA, Nolen Joy; SHKEDY, Ziv; VAN DER ELST, WimBookB1
92016Statistical evaluation of surrogate endpoints with examples from cancer clinical trialsBUYSE, Marc; MOLENBERGHS, Geert; PAOLETTI, Xavier; Oba, Koji; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, TomaszJournal ContributionA1
102016Exploring the relationship between the causal-inference and meta-analytic paradigms for the evaluation of surrogate endpointsVAN DER ELST, Wim; MOLENBERGHS, Geert; ALONSO ABAD, ArielJournal ContributionA1
112015Validating predictors of therapeutic success: A causal inference approachALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, GeertJournal ContributionA1
122015On the relationship between the causal-inference and meta-analytic paradigms for the validation of surrogate endpointsALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
132013Review: Clinical Trial Methodology: Surrogate endpoints: when should they be used?MOLENBERGHS, Geert; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
142013Statistical evaluation of surrogate endpoints in clinical studiesMOLENBERGHS, Geert; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz; BUYSE, MarcBook SectionB2